Global Electronic Drug Delivery Systems Market By Type (Electronic Wearable Infusion Pumps, Electronic Auto injectors, Electronic Injection Pens, Electronic Inhalers ), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD, Other Indications), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa), Market Trends & Forecast to 2027
Market Analysis and Insights: Global Electronic Drug Delivery Systems Market
Global electronic drug delivery systems market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 15.31 Billion by 2027 growing at a CAGR of 8.8% in the above-mentioned forecast period. The growth of this market is owing to multiple factors such as rise in prevalence of diseases, technological advancement in the design of electronic drug delivery systems.
The growing incidence of target ailments such as diabetes, cancer, among others is expected to drive the market growth for electronic drug delivery systems. Growing reimbursement policies of the government will act as a factor for the growth of the market. Rising advancement in technologies and designs will help in boosting the growth of the market. With increasing focus of quality of healthcare, the growing demand for biologics and mabs is among the major opportunities that will impact this markets growth in the forecast period to 2027.
This market report provides details of market share, new developments, product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Electronic Drug Delivery Systems Market Scope and Market Size
Electronic drug delivery systems market is segmented of the basis of type and indication. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on type, market is segmented into electronic wearable infusion pumps, electronic auto injectors, electronic injection pens and electronic inhalers. Electronic Wearable Infusion Pumps holds the largest share in the market due to growing occurrence of diabetes and rising infusion pumps for diabetes treatment.
Electronic drug delivery systems market has also been segmented based on the indication into diabetes, multiple sclerosis, cardiovascular disease, asthma & COPD, other indications. Diabetes segment is growing with the largest share in the market due to the availability of insulin pumps and injection pens.
Electronic Drug Delivery Systems Market Country Level Analysis
Global electronic drug delivery systems market is analysed and market size insights and trends are provided by country, type and indication as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to the large market share of the U.S. in electronic drug delivery systems market due to the high occurrence of chronic diseases such as diabetes, asthma and among others while the Asia-Pacific region is expected to grow at the highest growth rate in the forecast period 2020 to 2027 due to the presence of large targeted patient population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while provided forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Global electronic drug delivery systems market report also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for electronic drug delivery systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the electronic drug delivery systems market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Electronic Drug Delivery Systems Market Share Analysis
Global electronic drug delivery systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to electronic drug delivery systems.
The major players covered in the report are Merck KGaA, Medtronic, Insulet Corporation, Bayer AG, Novo Nordisk India Pvt Ltd, Companion Medical, Tandem Diabetes Care, Inc, F. Hoffmann-La Roche Ltd, Canè SpA, ViCentra B.V, Debiotech S.A., 3M, Jabil Inc, Phillips-Medisize, Nemera, AptarGroup, Inc, E3D Elcam Drug Delivery Devices, Renishaw plc., among other players domestic and global. Market share data is available for Global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Electronic Drug Delivery Systems Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.